| IV-65 Alicja Puszkiel Quantitative evaluation of the impact of CYP2D6 genetic polymorphisms on pharmacokinetics of tamoxifen and its metabolites in breast cancer patients Thursday 15:10-16:40 |
| IV-65 Alicja Puszkiel Quantitative evaluation of the impact of CYP2D6 genetic polymorphisms on pharmacokinetics of tamoxifen and its metabolites in breast cancer patients Thursday 15:10-16:40 |